Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2650 of 3173 entries
View as:

A Study to Learn How Different Amounts and Forms of the Study Medicine Called PF-06414300 Act in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06659250 Org: User:
Start: 09/27/24 End: 05/30/25 Due: 05/30/26

Palbociclib in Real World Practice

Phase: N/A Priority: Normal
NCT ID: NCT03280303 Org: User:
Start: 01/04/17 End: 12/22/22 Due: 12/22/23

Study The Effects Of Different Doses Of UK-369,003 In Men With Overactive Bladder

Phase: N/A Priority: Normal
NCT ID: NCT00479505 Org: User:
Start: 06/30/07 End: 06/30/08 Due: 06/30/09

A STUDY TO ESTIMATE THE EFFECT OF PF-06651600 ON THE PHARMACOKINETICS (PK) OF ORAL CONTRACEPTIVE (OC)

Phase: N/A Priority: Normal
NCT ID: NCT03608241 Org: User:
Start: 09/21/18 End: 11/23/18 Due: 11/23/19

Pharmacokinetics Study of ALO-02 and OxyContin

Phase: N/A Priority: Normal
NCT ID: NCT01557257 Org: User:
Start: 03/31/12 End: 05/31/12 Due: 05/31/13

A Pharmacokinetic Study Comparing PF-06439535 And Bevacizumab In Healthy Male Volunteers (REFLECTIONS B739-01)

Phase: N/A Priority: Normal
NCT ID: NCT02031991 Org: User:
Start: 01/31/14 End: 08/31/14 Due: 08/31/15

Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)

Phase: N/A Priority: Normal
NCT ID: NCT00084266 Org: User:
Start: 10/31/04 End: 03/31/10 Due: 03/31/11

Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01008852 Org: User:
Start: 12/31/09 End: 07/31/13 Due: 07/31/14

A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01405131 Org: User:
Start: 01/01/12 End: 02/20/12 Due: 02/20/13

Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater

Phase: N/A Priority: Normal
NCT ID: NCT00359632 Org: User:
Start: 11/30/08 End: 12/31/13 Due: 12/31/14

STUDY OF PF-06882961 IN PARTICIPANTS WITH AND WITHOUT VARYING DEGREES OF HEPATIC IMPAIREMENT

Phase: N/A Priority: Normal
NCT ID: NCT04604496 Org: User:
Start: 12/30/20 End: 01/10/22 Due: 01/10/23

Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04)

Phase: N/A Priority: Normal
NCT ID: NCT01643928 Org: User:
Start: 08/16/12 End: 03/14/16 Due: 03/14/17

A Study Comparing Two Forms of Tafamidis Without Food and the Amount of Tafamidis in the Blood With Food

Phase: N/A Priority: Normal
NCT ID: NCT05498701 Org: User:
Start: 09/29/22 End: 12/19/22 Due: 12/19/23

A Phase 1 Study To Estimate The Relative Bioavailability Of Fixed Combination Tablets Of Azithromycin And Chloroquine Compared To Co-Administered Individual Tablets Of Azithromycin And Chloroquine

Phase: N/A Priority: Normal
NCT ID: NCT00844207 Org: User:
Start: 02/28/09 End: 04/30/09 Due: 04/30/10

Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-Moderate Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT01301508 Org: User:
Start: 05/31/11 End: 11/11/11 Due: 11/11/12

To Examine the Effects of Axitinib Dose Reduction and Interruption for Adverse Event Management Among Patients Receiving Axitinib in for the Treatment of Advanced Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04682587 Org: User:
Start: 02/24/21 End: 04/05/21 Due: 04/05/22

Anaemetro I.V. Infusion 500mg Drug Use Investigation

Phase: N/A Priority: Normal
NCT ID: NCT03491228 Org: User:
Start: 07/31/15 End: 08/31/17 Due: 08/31/18

Study to Evaluate Patient Reported Outcome (PRO) and Physical Activity in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Endocrine Therapy or Endocrine Monotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04736576 Org: User:
Start: 02/24/21 End: 03/24/23 Due: 03/24/24

Post Marketing Observational Study of Reformulated BeneFIX

Phase: N/A Priority: Normal
NCT ID: NCT00835068 Org: User:
Start: 01/31/09 End: 10/31/13 Due: 10/31/14

Predictors of Response to Tofacitinib Treatment in Rheumatoid Arthritis Patients

Phase: N/A Priority: Normal
NCT ID: NCT04079920 Org: User:
Start: 09/22/20 End: 02/08/23 Due: 02/08/24

A Study to Learn How the Body Processes the Study Medicine Called PF-07923568 in People With Loss of Kidney Function

Phase: N/A Priority: Normal
NCT ID: NCT06037031 Org: User:
Start: 10/30/23 End: 07/03/24 Due: 07/03/25

ASIA CHOICES CHampix (Varenicline) Observational Investigation in the CEssation of Smoking

Phase: N/A Priority: Normal
NCT ID: NCT00808015 Org: User:
Start: 02/28/09 End: 07/31/10 Due: 07/31/11

Post Marketing Surveillance To Observe Safety And Efficacy Of Xyntha® In Subjects With Hemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT01790828 Org: User:
Start: 02/28/14 End: 08/31/14 Due: 08/31/15

Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02006290 Org: User:
Start: 03/31/14 End: 08/31/14 Due: 08/31/15

Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS

Phase: N/A Priority: Normal
NCT ID: NCT04697381 Org: User:
Start: 02/09/21 End: 04/15/24 Due: 04/15/25